CDK1 and lung adenocarcinoma: Combined with the results of survival analysis and other comprehensive analysis, it suggested that there might be a regulatory relationship between LINC00261 and CDK1, so loss of LINC00261 in lung adenocarcinoma patients might lead to CDK1 overexpression.